<DOC>
	<DOCNO>NCT02101112</DOCNO>
	<brief_summary>The purpose study determine whether bioavailability apixaban crush tablet suspended water mixed applesauce similar bioavailability apixaban whole tablet administer orally .</brief_summary>
	<brief_title>Bioavailability Apixaban Crushed Tablet</brief_title>
	<detailed_description>This study investigate bioavailability apixaban administer crush tablet suspend water crush tablet mixed applesauce compare whole tablet . The study result may allow enhancement apixaban label include alternative method apixaban administration , may benefit patient difficulty swallow .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy participant determine clinically significant deviation normal finding medical history , physical examination , electrocardiogram , vital sign , clinical laboratory test . Women childbearing potential allow . Must follow highly effective method contraception Any significant acute chronic medical illness History significant head injury within last 2 year , include individual base skull fracture Any major surgery within 4 week study drug administration anticipate within 2 week completion study Any gastrointestinal ( GI ) surgery GI disease could impact absorption study drug History Gilbert 's Syndrome Inability tolerate oral medication Inability venipunctured and/or tolerate venous access Use tobacco nicotinecontaining product ( include , limited , cigarette , pipe , cigar , chew tobacco , nicotine patch , nicotine lozenge , nicotine gum ) within 6 month prior study drug administration Any laboratory test result outside range normal , confirm repeat result : Platelet count &lt; 150,000 cells/µL Activated partial thromboplastin time &gt; upper limit normal ( ULN ) International normalize ratio &gt; ULN Alanine aminotransferase &gt; ULN Aspartate aminotransferase &gt; ULN Total bilirubin &gt; ULN Serum creatinine ≥1.5 mg/dL Hemoglobin &lt; low limit normal ( LLN ) Hematocrit &lt; LLN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>